Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Distinct Patterns of Blood Cytokines Beyond a Cytokine Storm Predict Mortality in COVID-19.
Herr C, Mang S, Mozafari B, Guenther K, Speer T, Seibert M, Srikakulam SK, Beisswenger C, Ritzmann F, Keller A, Mueller R, Smola S, Eisinger D, Zemlin M, Danziger G, Volk T, Hoersch S, Krawczyk M, Lammert F, Adams T, Wagenpfeil G, Kindermann M, Marcu C, Ataya ZWD, Mittag M, Schwarzkopf K, Custodis F, Grandt D, Schaefer H, Eltges K, Lepper PM, Bals R; CORSAAR Study Group. Herr C, et al. Among authors: hoersch s. J Inflamm Res. 2021 Sep 15;14:4651-4667. doi: 10.2147/JIR.S320685. eCollection 2021. J Inflamm Res. 2021. PMID: 34552347 Free PMC article.
Conservative management of COVID-19 associated hypoxaemia.
Supady A, Lepper PM, Bracht H, Moerer O, Muellenbach RM, Michels G, Fiedler MO, Kalenka A, Kochanek M, Mutlak H, Danziger G, Muenz S, Lunz D, Hoersch S, Staudacher D, Wengenmayer T, Zotzmann V. Supady A, et al. Among authors: hoersch s. ERJ Open Res. 2021 Jun 21;7(2):00204-2021. doi: 10.1183/23120541.00204-2021. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 34159186 Free PMC article.
Integrative Proteogenomics for Differential Expression and Splicing Variation in a DM1 Mouse Model.
Solovyeva EM, Utzinger S, Vissières A, Mitchelmore J, Ahrné E, Hermes E, Poetsch T, Ronco M, Bidinosti M, Merkl C, Serluca FC, Fessenden J, Naumann U, Voshol H, Meyer AS, Hoersch S. Solovyeva EM, et al. Among authors: hoersch s. Mol Cell Proteomics. 2024 Jan;23(1):100683. doi: 10.1016/j.mcpro.2023.100683. Epub 2023 Nov 21. Mol Cell Proteomics. 2024. PMID: 37993104 Free PMC article.
New insights into molecular changes in skeletal muscle aging and disease: Differential alternative splicing and senescence.
Solovyeva EM, Ibebunjo C, Utzinger S, Eash JK, Dunbar A, Naumann U, Zhang Y, Serluca FC, Demirci S, Oberhauser B, Black F, Rausch M, Hoersch S, Meyer AS. Solovyeva EM, et al. Among authors: hoersch s. Mech Ageing Dev. 2021 Jul;197:111510. doi: 10.1016/j.mad.2021.111510. Epub 2021 May 19. Mech Ageing Dev. 2021. PMID: 34019916 Free article.
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
Perez EA, Barrios C, Eiermann W, Toi M, Im YH, Conte P, Martin M, Pienkowski T, Pivot XB, Burris HA 3rd, Petersen JA, De Haas S, Hoersch S, Patre M, Ellis PA. Perez EA, et al. Among authors: hoersch s. Cancer. 2019 Nov 15;125(22):3974-3984. doi: 10.1002/cncr.32392. Epub 2019 Jul 18. Cancer. 2019. PMID: 31318460 Free article.
Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer.
Shah MA, Kang YK, Thuss-Patience PC, Ohtsu A, Ajani JA, Van Cutsem E, Hoersch S, Harle-Yge ML, de Haas SL. Shah MA, et al. Among authors: hoersch s. Gastric Cancer. 2019 Jul;22(4):803-816. doi: 10.1007/s10120-018-00923-7. Epub 2019 Jan 31. Gastric Cancer. 2019. PMID: 30706247 Clinical Trial.
Correction to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study.
Sakr Y, Ferrer R, Reinhart K, Beale R, Rhodes A, Moreno R, Timsit JF, Brochard L, Thompson BT, Rezende E, Chiche JD; IC-GLOSSARI Investigators and ESICM Trials Group. Sakr Y, et al. Intensive Care Med. 2018 Jan;44(1):144-152. doi: 10.1007/s00134-017-4979-6. Intensive Care Med. 2018. PMID: 29138898 Free PMC article.
Population pharmacokinetics and exposure-response of trastuzumab emtansine in advanced breast cancer previously treated with ≥2 HER2-targeted regimens.
Chen SC, Quartino A, Polhamus D, Riggs M, French J, Wang X, Vadhavkar S, Smitt M, Hoersch S, Strasak A, Jin JY, Girish S, Li C. Chen SC, et al. Among authors: hoersch s. Br J Clin Pharmacol. 2017 Dec;83(12):2767-2777. doi: 10.1111/bcp.13381. Epub 2017 Sep 3. Br J Clin Pharmacol. 2017. PMID: 28733983 Free PMC article. Clinical Trial.
39 results